Published in Immunol Today on August 01, 1996
Accommodation in organ transplantation. Curr Opin Organ Transplant (2008) 1.08
The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest (1998) 1.03
Infectious disease issues in xenotransplantation. Clin Microbiol Rev (2001) 0.91
Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. J Clin Invest (1997) 0.91
Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation. Am J Pathol (1997) 0.88
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol (2004) 0.83
The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83
Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo. Proc Natl Acad Sci U S A (1997) 0.80
Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation. Mol Med (1998) 0.79
Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78
Will xenotransplantation ever be feasible? J Am Coll Surg (1998) 0.78
Islet xenotransplantation: how sweet it is. J Clin Invest (1996) 0.77
Human leukocytes regulate ganglioside expression in cultured micro-pig aortic endothelial cells. Lab Anim Res (2012) 0.76
Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Clin Exp Immunol (1998) 0.75
The basis of allograft acceptance. Forum (Genova) (1997) 0.75
Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. Transplantation (1997) 0.75
The future of organ replacement: needs, potential applications, and obstacles to application. Transplant Proc (2006) 0.75
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Solid phase synthesis and restriction endonuclease cleavage of oligodeoxynucleotides containing 5-(hydroxymethyl)-cytosine. Nucleic Acids Res (1997) 3.54
The detection of mycobacterial DNA sequences in uncultured clinical specimens with cloned Mycobacterium tuberculosis DNA as probes. Tubercle (1988) 2.94
Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst (2000) 2.87
Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem (1983) 2.44
Cryptic speciation in the cosmopolitan and clonal human pathogenic fungus Aspergillus fumigatus. Evolution (2005) 2.37
Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med (1983) 2.33
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med (1995) 2.31
Expression of the viral thymidine kinase gene in herpes simplex virus-transformed L cells. J Virol (1974) 2.15
Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett (2001) 1.99
Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med (1994) 1.77
Sip2p and its partner snf1p kinase affect aging in S. cerevisiae. Genes Dev (2000) 1.77
Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation (1995) 1.70
Heme oxygenase: protective gene or Trojan horse. Nat Med (1998) 1.69
Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections. J Exp Med (1982) 1.59
Cryptic B cell response to renal transplantation. Am J Transplant (2013) 1.57
In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science (1995) 1.56
Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med (1983) 1.48
Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci (2000) 1.45
Nucleotide sequence analysis of RepFIC, a basic replicon present in IncFI plasmids P307 and F, and its relation to the RepA replicon of IncFII plasmids. J Bacteriol (1987) 1.44
Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis. Heart (2007) 1.42
Sterol regulation of acetyl coenzyme A carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins. J Lipid Res (1997) 1.38
Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today (1993) 1.31
Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation (1997) 1.29
Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med (1995) 1.26
Distribution of particulate matter and tissue remodeling in the human lung. Environ Health Perspect (2000) 1.26
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol (1991) 1.23
Distribution of basic replicons having homology with RepFIA, RepFIB, and RepFIC among IncF group plasmids. Plasmid (1986) 1.23
Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation (1994) 1.22
Deoxyribonucleic acid hybridization analysis for the detection of urogenital Chlamydia trachomatis infections in women. Am J Obstet Gynecol (1987) 1.21
Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant (2008) 1.15
Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 1.13
Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol (1992) 1.13
Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation (1991) 1.12
Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci U S A (1996) 1.12
Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med (1995) 1.11
Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J Immunol (1999) 1.10
The immunological barrier to xenotransplantation. Immunity (2001) 1.10
Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem (1998) 1.09
The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (2000) 1.09
Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol (1994) 1.08
CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol (2001) 1.07
A basic replicon of virulence-associated plasmids of Shigella spp. and enteroinvasive Escherichia coli is homologous with a basic replicon in plasmids of IncF groups. Infect Immun (1988) 1.07
Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc (1991) 1.07
Effect of T cell modulation on the translocation of bacteria from the gut and mesenteric lymph node. Ann Surg (1988) 1.06
Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha. Circulation (2000) 1.04
Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell Physiol (1996) 1.04
Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J Immunol (1999) 1.04
The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest (1998) 1.03
Xenotransplantation. New risks, new gains. Nature (2000) 1.03
The future promises of xenotransplantation. Ann N Y Acad Sci (1998) 1.03
Chronic rejection of mouse kidney allografts. Kidney Int (1999) 1.02
Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol (2000) 1.02
A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation (2001) 1.01
Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler Thromb (1992) 1.01
Extracorporeal shockwave lithotripsy of 2000 urinary calculi with the modulith SL-20: success and failure according to size and location of stones. J Endourol (2000) 1.01
Expression of epidermal growth factor receptors in human lung tumors. Cancer (1986) 1.00
Structural, molecular, and genetic analysis of the kilA operon of broad-host-range plasmid RK2. J Bacteriol (1991) 1.00
Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. J Immunol (1995) 1.00
Regulation of murine splenocyte responses by heparan sulfate. J Immunol (1991) 0.99
Cellular proteins specifically bind to the 5'-noncoding region of hepatitis C virus RNA. Virology (1995) 0.99
The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation (1991) 0.99
Complications of ankle fractures in diabetic patients. Orthop Clin North Am (2001) 0.99
Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol Anim (1994) 0.99
Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies. J Immunol (1996) 0.99
ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc (1987) 0.98
Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood (1985) 0.98
Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. J Immunol (1995) 0.97
Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol (1997) 0.97
Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol (1998) 0.97
Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation (1995) 0.96
Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest (1995) 0.96
Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol (1991) 0.96
Characterization of the basic replicons of the chimeric R/Ent plasmid pCG86 and the related Ent plasmid P307. Plasmid (1984) 0.96
Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation (1987) 0.95
Xenotransplantation and other means of organ replacement. Nat Rev Immunol (2001) 0.94
Modulation of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol (1999) 0.94
Dietary fat and breast cancer. Annu Rev Nutr (2000) 0.93
Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant (2008) 0.93
ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplantation. Transplant Proc (1989) 0.93
In vitro lymphocyte-differentiating effects of thymulin (Zn-FTS) on lymphocyte subpopulations of severely malnourished children. Am J Clin Nutr (1994) 0.92
Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas. Gene Ther (1999) 0.92
Differentiation of lethal and nonlethal, kor-regulated functions in the kilB region of broad host-range plasmid RK2. Plasmid (1991) 0.92
Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J Immunol (1998) 0.92
Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta (1999) 0.92
Bone healing of tibial lengthening is enhanced by hyperbaric oxygen therapy: a study of bone mineral density and torsional strength on rabbits. J Trauma (1998) 0.91
IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. J Immunol (1999) 0.91
The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol (1997) 0.91
A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds. Gene Ther (2000) 0.91
Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. J Clin Invest (1997) 0.91
Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development. J Clin Immunol (1997) 0.91